For research use only.This product is not FDA approved and is strictly for laboratory, academic, or institutional research — not for human or animal consumption or for any clinical or medical use.Not FDA approved · Not for human useLearn more about research use only
CJC-1295 DAC

Research Compound

CJC-1295 DAC (Modified GRF 1-29 with Drug Affinity Complex)

Research use only
BatchFLL-0629HPLC purity99.46%
$79.99In stock

CJC-1295 with DAC is tetrasubstituted GRF(1-29) carrying a maleimidopropionyl group at Lys30 that binds albumin covalently, extending its action.

Bundle & saveHigher quantities. Lower cost per vial.
Expected arrival2–5 business days
HPLC verified99%+ measured
Lab-tested COAPass, every lot
Codex Research
Lab testedPass
Batch verifiedMeets research standards
Full reportPDF download below
Batch COAPublished for each batch

Certificate of Analysis

CJC-1295 DAC · 5 mg sample

2606AFL1031.3703LOT FLL-0629
99.46%HPLC purityPassedMeets research
specifications

Lot FLL-0629 · Reported Jul 14, 2026 · Pass

CJC-1295 DAC
TestSpecificationMethodResultStatus
PurityReportHPLC (TM-13)99.459% · 6.27 mg/unitTested
Endotoxin≤ 70.00 EU/mg—1.00 EU/mgPass
PASSLAB TESTED

Analysis performed in accordance with internal SOPs.
For laboratory research use only, not for human consumption.

Compound data

CJC-1295 DAC CAS number, formula and molecular weight

CJC-1295 DAC (CAS 446262-90-4) has the molecular formula C165H269N47O46 and a molecular weight of 3647.2 g/mol.

CAS number
446262-90-4
Molecular formula
C165H269N47O46
Molecular weight
3647.2 g/mol
PubChem CID
91971820

Source: PubChem CID 91971820 · checked November 2026

Research insights

Research Overview

CJC-1295 with DAC is a modified GHRH(1-29) analog carrying a maleimidopropionyl group, the drug affinity complex, on an added lysine at the end of the chain. That group forms a bond with albumin, the protein present in blood in the greatest amount, which extends how long the peptide remains available in research models.

Research FocusExtended GHRH receptor signalling
Compound ClassAlbumin-binding GHRH analog
Research AreaGH-Axis Research
01

What is CJC-1295 DAC?

CJC-1295 DAC starts from the same stabilized GHRH(1-29) sequence as the No-DAC version, with four amino acids swapped to resist enzymatic breakdown.

What makes it different is the drug affinity complex, a maleimidopropionyl group attached to an added lysine at the end of the chain. That group reacts with albumin and effectively lets the peptide ride on a far larger carrier protein instead of being cleared quickly.

The practical difference for research design is the shape of the signal. The No-DAC version gives a short pulse at the GHRH receptor; the DAC version gives a long, steady one. Studies comparing pulsatile against continuous receptor signalling often run both.

Compound classAlbumin-binding GHRH analog
02

Mechanism of Action

CJC-1295 DAC is studied as a long-acting GHRH receptor agonist, where covalent albumin binding through the drug affinity complex extends availability and produces sustained rather than pulsatile receptor signalling in research models. Typical in-vitro work includes albumin-conjugation analysis, cAMP accumulation assays, and side-by-side comparison with the No-DAC analog.
03

Key Research Areas

CJC-1295 DAC is studied across these areas of laboratory research:

Extended GHRH receptor signalling
Albumin-binding peptide chemistry
Pulsatile vs sustained signalling
GH-axis comparative studies
04

Research Context

Storage−20 °C, sealed, protected from light
HandlingTrained personnel, standard laboratory PPE
Important

CJC-1295 DAC is supplied strictly as a laboratory research material. This product is not FDA approved and is not for human or animal use.

Product data

CJC-1295 DAC specifications

Lot FLL-0629 · 99.46% HPLC
Compound
CJC-1295 with DAC, tetrasubstituted GRF(1-29) plus an albumin-binding group
Backbone
Modified GRF 1-29: D-Ala at position 2, Gln at 8, Ala at 15, Leu at 27
The DAC group
A maleimidopropionyl moiety at Lys30 that forms a covalent bond with circulating albumin
Residues
30, one more than the no-DAC form
Receptor in the literature
The GHRH receptor on the anterior pituitary
Note on CAS numbers
Vendor catalogues apply CAS 863288-34-0 to both the DAC and no-DAC forms. The two are different molecules; check the stated residue count and the presence of the Lys30 group
Not the same as
CJC-1295 No DAC, the 29-residue backbone without the albumin-binding group
Form
Lyophilized powder, sealed vial
Vial sizes
5 mg, 10 mg
Purity, lot FLL-0629
99.46% by HPLC
Measured content, 5 mg vial
6.27 mg by HPLC assay
Endotoxin, lot FLL-0629
1.00 EU/mg against a 70.00 EU/mg limit
Storage
−20 °C, sealed, protected from light
Availability
CJC-1295 DAC for sale online in 5 mg and 10 mg vials. Ships within the United States.
Intended use
Laboratory research only. Not for human or veterinary use.

Lot values come from the batch certificate of analysis. Identifiers come from PubChem and UniProt.

Published research

What does research show about CJC-1295 DAC?

5 cited sources · laboratory and in-vitro research only

01

What is CJC-1295 with DAC?

It is modified GRF(1-29), the four-substitution GHRH fragment, with one addition: a maleimidopropionyl group at Lys30. That group is the Drug Affinity Complex, and it binds covalently to albumin in circulation.

02

What do the four backbone substitutions do?

They protect the peptide from the enzyme that cuts native GHRH. Frohman and colleagues identified dipeptidylpeptidase IV as cutting between residues 2 and 3, and found a D-amino acid at position 1 or 2 blocked the hydrolysis.

03

Why attach the peptide to albumin at all?

Because the unmodified fragment does not last. Frohman and colleagues measured a plasma half-life of 6.8 minutes for the intact native hormone, with the cleaved product carrying less than a thousandth of its activity. Covalent albumin binding is a way around that.

04

What did the knockout-mouse study report?

Alba and colleagues found that once-daily CJC-1295 normalised growth in mice lacking growth-hormone-releasing hormone, which is the clearest in-vivo evidence that the modified backbone still works at the receptor.

05

How does it differ from the no-DAC form?

By one group and one residue. The no-DAC form is the 29-residue backbone on its own. Adding the Lys30 maleimidopropionyl group is the only structural difference, and it is the whole reason the two behave differently over time.

06

Is it treated differently in anti-doping?

No. The World Anti-Doping Agency lists growth hormone-releasing factors in section S2 of its Prohibited List, prohibited at all times in signatory sports, which covers both forms.

References

  1. 1PubChem. CJC-1295 · modified GRF(1-29) compound summary.PubChem ↗
  2. 2Frohman LA, Downs TR, Heimer EP, Felix AM. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. J Clin Invest. 1989;83(5):1533–1540.Study ↗
  3. 3Frohman LA, Downs TR, Williams TC, Heimer EP, Pan YC, Felix AM. Rapid enzymatic degradation of growth hormone-releasing hormone by plasma. J Clin Invest. 1986;78(4):906–913.Study ↗
  4. 4Alba M, Fintini D, Sagazio A, et al. Once-daily administration of CJC-1295, a long-acting GHRH analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006;291(6):E1290–E1294.PubMed ↗
  5. 5World Anti-Doping Agency. Prohibited List, section S2 · growth hormone-releasing factors, prohibited at all times.Study ↗

Research use only. Studies listed describe laboratory and in-vitro research. They are not claims about any use of this product.

Advancing knowledge. Enabling discovery. Supporting rigorous laboratory research.Research with confidence →

Handling guidelines

Storage & Handling

Proper storage and handling help maintain the integrity and quality of this compound for accurate research results.

Lyophilized (unopened)Store at -20 °C, sealed and protected from light and moisture.
Long-termKeep sealed at a steady −20 °C. Avoid repeated warming and cooling.
Before HandlingInspect the vial and discard if moisture, particulates, or discoloration are present.
1Storage Protocol
Unopened Vial

Store at −20 °C (freezer), sealed.

−20 °CSEALED
Protect from Light

Keep in original packaging and away from direct light.

DarkSTORAGE
Avoid Temperature Swings

Keep the sealed vial at a steady storage temperature. Repeated warming and cooling may affect stability.

StabilityRISK
2Handling WorkflowA simple workflow for best practices.
Remove from storageFrom its correct storage condition.
Allow equilibrationRoom temperature, 10–15 minutes.
Inspect vialClarity, particulates and label.
Prepare for researchClean, controlled lab setting.
3What to Look ForInspect before handling.
Dry, intact lyophilized cake or powder
No visible moisture inside the vial
No unexpected discoloration
Intact vial, seal and cap
If any abnormalities are present, discard the vial.
4Researcher ChecklistUse this quick checklist before beginning.
Storage temperature confirmed
Vial condition checked
Light exposure minimized
Appropriate laboratory PPE available
Storage conditions documented
5Additional NotesTechnical information for optimal handling.
Equilibration TimeAllow 10–15 minutes at room temperature before opening.
Laboratory EnvironmentHandle in a clean, controlled setting using standard PPE (gloves, lab coat, eye protection), by trained personnel only.
Stability ConsiderationsMinimize time at room temperature and avoid repeated freeze–thaw cycles.
For Research Use OnlyNot for human or animal use. Follow all applicable laboratory safety protocols.
Proper storage and handling support the highest level of compound quality for your research.Research with confidence →

Important information

Intended Use & Legal Disclaimer

This compound is sold solely for in vitro laboratory research. It is not a drug, food, cosmetic or medical device, and it must not be used in humans or animals. It must not be administered to any living subject or used in any diagnostic application.

Not FDA ApprovedFor research use only
Not for Human or Animal UseDo not ingest or administer
Research ResponsibilityBuyer confirms compliant handling and disposal
For research use only

Supplied strictly for in vitro laboratory research by qualified professionals.

  • Not for human use
  • Not for veterinary use
  • Not for diagnostic use
Regulatory Status

This product is not approved by the FDA or any other regulatory authority for human or veterinary use.

Not FDA ApprovedFor research use only
Use Restrictions

This compound must not be used in humans or animals under any circumstances.

Not for Human or Animal UseDo not ingest or administer.
Researcher Responsibility

By purchasing, the buyer confirms they are acting in a research capacity and accepts full responsibility for compliant handling, storage, and disposal.

For Qualified ResearchersFollow proper handling and disposal procedures.
CJC-1295 DAC research vialCJC-1295 DAC
Additional information

Not evaluated by the FDA and not intended to diagnose, treat, cure, or prevent any disease. Sale is restricted to qualified research professionals and certified laboratories.

Codex Research accepts no liability for use outside controlled laboratory research.

In vitro research onlyPurchase of this product is subject to the Codex Research Terms of Sale and the research-use attestation made at checkout.View full terms of sale →

Purchase terms

Terms of Sale

All sales by Codex Research are final. Damaged, incorrect or undelivered orders reported within 48 hours of delivery are resolved under our Return & Refund Policy. Buyers must be qualified professionals and assume full responsibility for safe handling and regulatory compliance. Every batch is lab tested. Batch-specific Certificates of Analysis are available on our COAs page.

All sales finalTemperature-sensitive materials
Buyer responsibilityQualified professionals only
Lab testedEvery batch tested
Research use onlyNot for human or animal use
01
Orders & Payment
  • All sales are final once an order ships.
  • Orders can be cancelled before they are dispatched.
  • Checkout requires the research-use attestation and the 21+ confirmation.
  • Card payments are refunded to the original card. Bitcoin payments are refunded in Bitcoin at the order’s USD value.
02
Shipping
  • Orders placed by 3 PM ET ship the same business day.
  • Free standard shipping on orders over $100, and free 2-Day on orders over $175.
  • We ship within the United States only. No freight forwarders.
  • Parcels are packed discreetly. Accurate delivery details are the buyer’s responsibility.
03
Claims & Refunds
  • Report damaged, incorrect or undelivered orders within 48 hours of delivery.
  • Verified claims are resolved under our Return & Refund Policy.
  • Bundles are refunded as a whole, not item by item.
  • Memberships are non-refundable.
04
Buyer Responsibility
  • Purchases are limited to qualified research professionals and institutions.
  • The buyer accepts responsibility for compliant handling, storage and disposal.
  • Products are for laboratory research only, not for human or animal use.
  • Codex Research accepts no liability for use outside controlled laboratory research.
Full terms, shipping and refund policies apply to every order.View full terms of sale →

For research use only · Not for human consumption

Content last reviewed November 2026 · Reviewed by the Codex Research quality team

Learn more: How to read a COA · Purity grades explained · Third-party testing explained · How vials handle shipping

Glossary

Key terms on this page

Plain-English definitions from the Codex glossary.

FAQ

Questions about CJC-1295 DAC

What is CJC-1295 DAC?

CJC-1295 DAC starts from the same stabilized GHRH(1-29) sequence as the No-DAC version, with four amino acids swapped to resist enzymatic breakdown. What makes it different is the drug affinity complex, a maleimidopropionyl group attached to an added lysine at the end of the chain.

How is CJC-1295 DAC studied in the laboratory?

CJC-1295 DAC is studied as a long-acting GHRH receptor agonist, where covalent albumin binding through the drug affinity complex extends availability and produces sustained rather than pulsatile receptor signalling in research models. Typical in-vitro work includes albumin-conjugation analysis, cAMP accumulation assays, and side-by-side comparison with the No-DAC analog.

Does CJC-1295 DAC come with a certificate of analysis (COA), and what purity is it?

Yes. Every CJC-1295 DAC vial ships with the certificate of analysis for its lot. The current lot (FLL-0629) tested at 99.46% purity by HPLC, with identity confirmed by mass spectrometry, and its full COA is published on this page as a PDF.

Is CJC-1295 DAC for sale online, and how much does it cost?

Yes. CJC-1295 DAC is for sale online at Codex Research from $79.99 for the 5 mg vial, for laboratory research only. Orders placed before 3 PM ET on a weekday ship the same day. Standard shipping is $9.99 and is free on orders over $100.

Where can I buy CJC-1295 DAC?

Codex Research sells CJC-1295 with DAC online as a lyophilized research peptide in 5 mg and 10 mg vials. The current lot, FLL-0629, tested at 99.46% purity by HPLC, and its certificate is published on this page. Weekday orders placed before 3 PM ET ship the same day.

What does DAC stand for?

Drug Affinity Complex. It is the maleimidopropionyl group attached at Lys30, and its job is to form a covalent bond with albumin so the peptide travels with a long-lived carrier protein rather than clearing on its own. Without that group, the same 29-residue backbone is the no-DAC form.

Is CJC-1295 DAC the same as the no-DAC version?

No. They share the same 29-residue backbone, but the DAC form carries an extra lysine at position 30 with the albumin-binding group on it. Confusingly, vendor listings often give both the same CAS number, 863288-34-0, so check the residue count: 30 for the DAC form, 29 without it.

Is CJC-1295 DAC FDA approved?

No. Neither form of CJC-1295 is approved by the FDA for any use, and neither is a dietary supplement ingredient. This vial holds the 30-residue DAC form, modified GRF(1-29) with the Lys30 albumin-binding group, supplied strictly as laboratory research material for in-vitro work, not for human or animal use.

Is CJC-1295 DAC for human use?

No. CJC-1295 DAC is sold strictly for in-vitro laboratory research. This product is not FDA approved, is strictly for laboratory, academic or institutional research, and is not for human or animal consumption. Buyers must confirm they are 21 or older and purchasing for research.

More answers in the full FAQ
Shipping guides

Shipping CJC-1295 DAC to your state

Same-day dispatch before 3 PM ET, insulated packaging and lot-matched certificates to all 50 states.

Related products

TesamorelinGH axis

Research peptide

Tesamorelin

GH-Axis Research

Tesamorelin is a 44-residue GHRH analog carrying a trans-3-hexenoyl group on Tyr1, studied in GHRH-receptor and peptide-stability research. Lot-tested by HPLC.

99%+Purity+162Reward pts
$64.99
View product
NewIpamorelinGH axis

Research peptide

Ipamorelin

GH-Axis Research

Ipamorelin is a five-residue synthetic peptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, studied as a selective agonist at the ghrelin receptor. Lot-tested by RP-HPLC.

99%+Purity+87Reward pts
$34.99
View product
CJC-1295 / IpamorelinGH axis

Research peptide

CJC-1295 / Ipamorelin

GH-Axis Research

A single vial pairing CJC-1295 without DAC, a tetrasubstituted GRF(1-29) analog, with Ipamorelin, a five-residue ghrelin-receptor agonist. Lot-tested by RP-HPLC.

99%+Purity+187Reward pts
$74.99
View product
CJC-1295 No DACGH axis

Research peptide

CJC-1295 No DAC

GH-Axis Research

CJC-1295 without DAC is modified GRF(1-29) carrying four substitutions at positions 2, 8, 15 and 27 that resist the plasma enzyme cutting native GHRH.

99%+Purity+174Reward pts
$69.99
View product
SermorelinGH axis

Research peptide

Sermorelin

GH-Axis Research

Sermorelin is GRF(1-29) amide, the shortest fragment of human GHRH that keeps full activity at the GHRH receptor, studied in pituitary and peptide-stability research.

99%+Purity+162Reward pts
$64.99
View product
Tesamorelin / IpamorelinGH axis

Research peptide

Tesamorelin / Ipamorelin

GH-Axis Research

A blend of tesamorelin, a GHRH(1-44) analog, with ipamorelin, a selective ghrelin-receptor pentapeptide, studied as two separate receptor pathways.

99%+Purity+212Reward pts
$84.99
View product
BestsellerGLP-3 (RT)Metabolic

Research peptide

GLP-3 (RT)

Metabolic Research

A triple agonist at the GIP, GLP-1 and glucagon receptors, three members of the class B1 glucagon subfamily, supplied for receptor-pharmacology research.

99%+Purity+199Reward pts
$79.99
View product
BPC-157Repair

Research peptide

BPC-157

Tissue-Repair Research

BPC-157 is a 15-amino-acid synthetic peptide taken from a gastric-juice protein, studied in endothelial, fibroblast and growth-factor research. Lot-tested by HPLC and LC-MS.

99%+Purity+149Reward pts
$59.99
View product
GHK-CuDermal

Research peptide

GHK-Cu

Dermal Matrix Research

GHK-Cu is the copper(II) complex of the tripeptide Gly-His-Lys, a constituent of human plasma, studied in fibroblast matrix and copper-transport research. Lot-tested by HPLC.

99%+Purity+99Reward pts
$39.99
View product
TrendingNAD+Cellular

Research peptide

NAD+

Cellular Research

NAD+ is nicotinamide adenine dinucleotide, the oxidized redox coenzyme and sirtuin substrate, supplied as lyophilized powder in 500 mg and 1000 mg vials. Lot-tested by LC-MS.

99%+Purity+224Reward pts
$89.99
View product

From lab to your door

Every compound.Every lot, proven.

U.S.-made research vials, shipped with lot-matched, lab-tested COAs you can scan straight off the label.